Newly referred patients – n (%) | |||||
Objective assessment | |||||
Level 1 | Level 2 | Level 3 | Total | ||
Endocrinologists´ assessment | Level 1 | 9 (4.3) | 18 (8.6) | 7 (3.3) | 34 (16.3) |
Level 2 | 0 | 75 (36.9) | 40 (19.1) | 115 (55.0) | |
Level 3 | 0 | 13 (6.2) | 47 (22.5) | 60 (28.7) | |
Total | 9 (4.3) | 106 (50.7) | 94 (45.0) | 209 (100) | |
Observed agreement: 62.7 %, kappa = 0.39 (CI: 0.29–0.50), McNemar’s test for marginal distribution: p < 0.0001, Bowker’s test for symmetry: p < 0.0001 | |||||
Long-term follow-up patients – n (%) | |||||
Objective assessment | |||||
Level 1 | Level 2 | Level 3 | Total | ||
Endocrinologists´ assessment | Level 1 | 7 (1.8) | 12 (3.2) | 1 (0.3) | 20 (5.3) |
Level 2 | 5 (1.3) | 162 (42.6) | 51 (13.4) | 218 (57.4) | |
Level 3 | 0 | 46 (12.1) | 96 (25.38) | 142 (37.4) | |
Total | 12 (3.2) | 220 (57.9) | 148 (38.9) | 380 (100) | |
Observed agreement: 69.7 %, kappa = 0.45 (CI: 0.36–0.53), McNemar’s test for marginal distribution: p = NS, Bowker’s test for symmetry: p = NS |